A Novel Mechanism to Drive Castration-Resistant Prostate Cancer

Salma Kaochar1, Nicholas Mitsiades1

  • 1Department of Medicine, Baylor College of Medicine, Houston, TX 77030, USA; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA.

Insights

Prostate cancer relies on androgen receptor signaling. Researchers found that a reduced androgen-inactivating enzyme increases local androgens, promoting cancer growth even after treatment.

Area of Science:

  • Oncology
  • Endocrinology
  • Molecular Biology

Background:

  • Androgen receptor (AR) signaling is a key driver in prostate adenocarcinoma development and progression.
  • Despite androgen deprivation therapy (ADT), persistent intratumoral androgens contribute to castration-resistant prostate cancer (CRPC).
  • Increased in situ androgen synthesis is a known mechanism for intratumoral androgen persistence.

Purpose of the Study:

  • To investigate alternative mechanisms contributing to local androgenic exposure in prostate cancer.
  • To identify factors that enhance androgen availability in the tumor microenvironment, particularly in the context of CRPC.

Main Methods:

  • The study focused on the role of androgen-inactivating enzymes.
  • Investigated the impact of enzyme downregulation on local androgen levels.
  • Utilized findings from Sharifi and colleagues' recent report.

Main Results:

  • A novel mechanism enhancing local androgenic exposure was identified.
  • Downregulation of a specific androgen-inactivating enzyme was found to increase androgen levels within the tumor.
  • This enzymatic shift contributes to AR signaling in prostate cancer.

Conclusions:

  • Reduced activity of androgen-inactivating enzymes represents a significant mechanism for increased local androgen availability in prostate cancer.
  • Targeting these enzymes could offer new therapeutic strategies for managing CRPC.
  • Understanding these pathways is crucial for overcoming treatment resistance.

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.2K
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
7.0K
Energy to Drive Translocation01:37

Energy to Drive Translocation

Mitochondrial protein import is powered by two distinct energy sources: ATP hydrolysis and electrochemical potential across the inner membrane. Newly synthesized precursors are bound by cytosolic chaperones of the Hsp70 family, which guide them to the import receptors on the mitochondrial surface. Utilizing the energy of ATP hydrolysis, Hsp70 chaperones transfer these precursors to the TOM receptors on the mitochondrial outer membrane.
Generally, polypeptides are unfolded by two distinct...
2.9K
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
6.6K
Resistivity01:22

Resistivity

When a voltage is applied to a conductor, an electrical field is generated, and charges in the conductor feel the force due to the electrical field. The current density that results depends on the electrical field and the properties of the material. In some materials, including metals at a given temperature, the current density is approximately proportional to the electrical field. In these cases, the current density can be modeled as:
4.6K